Scientific article
Editorial
OA Policy
English

Cobicistat : A case of mislabelled drug-drug interaction risk?

Published inBritish journal of clinical pharmacology, vol. 86, no. 5, p. 834-836
Publication date2020-05
First online date2020-03-06
Keywords
  • HIV/AIDS
  • Cytochrome P450
  • Drug interactions
  • Anti-HIV Agents / pharmacology
  • Cobicistat / pharmacology
  • Darunavir
  • Drug Interactions
  • Drug Labeling
  • HIV Infections / drug therapy
  • Humans
  • Pharmaceutical Preparations
Citation (ISO format)
BURGER, David M, CALMY, Alexandra, MARZOLINI, Catia. Cobicistat : A case of mislabelled drug-drug interaction risk? In: British journal of clinical pharmacology, 2020, vol. 86, n° 5, p. 834–836. doi: 10.1111/bcp.14262
Main files (1)
Article (Published version)
Identifiers
ISSN of the journal0306-5251
26views
5downloads

Technical informations

Creation02/23/2022 2:41:01 PM
First validation11/22/2023 2:52:15 PM
Update time11/22/2023 2:52:15 PM
Status update11/22/2023 2:52:15 PM
Last indexation11/01/2024 6:48:31 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack